HTG Molecular Diagnostics Inc (OTCPK:HTGMQ)
$ 0.0002 -0.000199 (-99.5%) Market Cap: - Enterprise Value: -2.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript

Nov 12, 2019 / 09:30PM GMT
Release Date Price: $140.49 (-3.22%)
Operator

Greetings, and welcome to the HTG Molecular Diagnostics Inc. Third Quarter 2019 Earnings Call. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the conference over to your host, Monique Kosse, LifeSci Advisors. Please go ahead, ma'am.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, Jerry. Earlier today, HTG released its financial results for the quarter ended September 30, 2019.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal security laws, including statements regarding possible additional collaborations with pharma customers; anticipated continued growth in RUO profiling business and related revenue; expected growth in and benefit from pharma programs and collaborations; product development and commercialization activities; revenue expectations for the full year 2019; and projects expected to occur in 2020.

These forward-looking statements are subject to numerous risks and uncertainties, many of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot